Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03198871 · ClinicalTrials.gov registry record · Phase 4
IV Acetaminophen for Post-Operative Pain Management in Enhanced Recovery After Surgery (ERAS) Population
A Phase 4 study, sponsored by Kathirvel Subramaniam.
- Completed
- Registry status
- Phase 4
- Development phase
- 180
- Enrollment target
NCT03198871: Completed Phase 4 study, sponsored by Kathirvel Subramaniam.
NCT03198871 is a Phase 4 study that has completed, run by Kathirvel Subramaniam. The registered enrollment target is 180 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (65% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03198871, a Phase 4 study, has completed, sponsored by Kathirvel Subramaniam.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 180 participants
- Enrollment target
Study Summary
Number of patients with unsatisfactory pain relief defined as average visual analog scale (VAS) more than 5 with or without requirement of IVPCA for pain relief during the first 48 hours postoperative period will be compared between the two groups and form the primary outcome for the study. Postoperative pain intensity will be measured by Visual Analog Scale (VAS) with 0- being no pain and 10-being maximum pain and the analgesic efficacy in both groups will also be evaluated by the amount of total narcotic consumption (measured with IV morphine equivalent doses of analgesics used to provide pain relief).
Primary Outcome
Number of patients with unsatisfactory pain relief defined as average numeric rating scale (NRS) more than 5 will be compared between the two groups. This may include patients using IVPCA for pain relief during the first 48 hours postoperative.
Interventions
- DRUG Acetaminophen Injectable Product
- DRUG Sodium Chloride 0.9%, Intravenous
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2018-05-24 |
| Est. Completion | 2020-11-30 |
| Phase | Phase 4 |
What the finished NCT03198871 record still lists
NCT03198871 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (65% lower).
The record links to 0 conditions, and to 2 interventions - of which Acetaminophen Injectable Product is the first listed.
NCT03198871 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03198871 about?
NCT03198871 is a clinical study titled "IV Acetaminophen for Post-Operative Pain Management in Enhanced Recovery After Surgery (ERAS) Population". Number of patients with unsatisfactory pain relief defined as average visual analog scale (VAS) more than 5 with or without requirement of IVPCA for pain relief during the first 48 hours postoperative period will be compared between the two groups and form the primary outcome for the study. Postoper...
What is the current status of trial NCT03198871?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 180 participants. The study started on 2018-05-24. Estimated completion is 2020-11-30.
What interventions are being tested in trial NCT03198871?
The interventions under investigation include: Acetaminophen Injectable Product (DRUG), Sodium Chloride 0.9%, Intravenous (DRUG).
Who is sponsoring clinical trial NCT03198871?
This trial is sponsored by Kathirvel Subramaniam, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03198871's enrollment target sits among peer trials
180 466th of 2000 higher than 1,525 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI